Company: INVUP
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022223
Chunk: 109

Company: Investview, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 109
---
     7,360 
  
    Domain names [1] 
     40,310 
  
    Raw materials 
     149,260 
  
    Manufacturing equipment 
     717,020 
  
    Total assets acquired 
    $915,445 

    Accounts payable 
    $323 
  
    Customer deposits 
     572,386 
  
    Total liabilities assumed 
    $572,709 

    Net assets acquired 
     342,736 

    Consideration [2] 
    $1,207,614 
  
    Fair value of noncontrolling interest in ELRT Technologies, LLC 
     8,823 
  
    Total 
     1,216,437 

    Goodwill 
    $873,701 

    [1]
    Domain
    names were deemed to have an indefinite life; therefore, amounts are not amortized, but rather are assessed for impairment as further
    discussed in our impairment policy.

    [2]
    This
    amount is equal to the $1,780,000 purchase price less $572,386 of customer deposits collected by Renu Labs, Inc. prior to acquisition.

    31

INVESTVIEW, INC.

NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF SEPTEMBER 30, 2025

(Unaudited)

NOTE
14 – INCOME TAXES

For
the periods ended September 30, 2025 and 2024, the Company used a discrete effective tax rate method for recording income taxes,
as compared to an estimated full year annual effective tax rate method, as an estimate of the annual effective tax rate cannot be made.

Provision
for Income taxes for the three and nine months ended September 30, 2025 was $4,000 and $15,000, respectively, resulting in an effective
tax rate of (0.5)% and (1.4)%, respectively. Provision for Income taxes for the three and nine months ended September 30, 2024 was $95,287
and $864,429, respectively, resulting in an effective tax rate of (13.3)% and 38.3%, respectively. The provision for income taxes was
primarily impacted by pretax book income, permanent differences, and by the change in valuation allowance on deferred tax assets.

NOTE
15 – SUBSEQUENT EVENTS

In
accordance with ASC Topic 855, Subsequent Events